SAN DIEGO, Jan. 16, 2019 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today the release of its newest cannabidiol (CBD) product Real Scientific Hemp Oil™ (RSHO™) Maximum Strength.
RSHO™ Maximum Strength is the company's most potent full-spectrum product, containing 4,500 mg of CBD in each 10-gram oral applicator to support overall wellness. This product features both CBD and CBDa in a proprietary blend of the company's premium hemp oils, including its RSHO™ Green Label raw CBD oil and RSHO™ Gold filtered CBD oil. It is also available in one-gram containers.
"We developed Real Scientific Hemp Oil Maximum Strength because of our promise to continuously evolve and lead the industry with quality and innovation," said HempMeds® President Todd Morrow. "This product brings consumers a new level of full spectrum concentration to assist those who can benefit most from a higher concentration oral applicator product. We will continue to drive industry innovation and offer products that stand by our promise to deliver safe, high-quality and meaningful ingestible or topical formulations that can help make a difference for those who benefit from CBD."
HempMeds® was the first company to ever bring hemp-based CBD oil products to market in the U.S. in 2012 -- and the first to both make CBD products available in bulk for U.S. consumers and provide high-quality CBD hemp oil to customers around the world. HempMeds® was also the first-ever company to receive historic federal government import approvals for its CBD products in the nations of Argentina, Brazil, Mexico and Paraguay.
Learn more about HempMeds® RSHO™ Maximum Strength and other exciting CBD hemp oil products at HempMeds.com.
HempMeds® is a corporate portfolio company of Medical Marijuana, Inc. (OTC: MJNA) and the Company's exclusive master distributor and contracted marketing company, handling sales and distribution.
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.'s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.'s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.'s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
SOURCE Medical Marijuana, Inc.